A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients

NCT00001084 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

500

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Indinavir sulfate
DRUG: Lamivudine
DRUG: Stavudine
DRUG: Zidovudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)